| Bioactivity | Y08262 is a potent and selective CBP bromodomain inhibitor. Y08262 selectively inhibits the CBP bromodomain with an IC50 value of 73.1 nM. Y08262 can be used for the research of acute myeloid leukemia (AML)[1]. |
| Target | IC50: 73.1 nM (CBP bromodomain). |
| Name | Y08262 |
| CAS | 2450965-18-9 |
| Formula | C24H21FN4O3 |
| Molar Mass | 432.45 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Xiang Q, et al. Discovery of a potent and selective CBP bromodomain inhibitor (Y08262) for treating acute myeloid leukemia. Bioorg Chem. 2023 Oct 30;142:106950. |